Biologics Contract Development Market Size, Share & Trends Analysis Report By Source (Mammalian, Microbial), By Service Type, By Indication (Oncology, Immunological Disorders), By Region And Segment Forecasts, 2023 - 2030
- Report ID: GVR-4-68038-983-8
- Number of Pages: 150
- Format: Electronic (PDF)
- Historical Range: 2018 - 2021
- Industry: Healthcare
Market Segmentation
- Biologics Contract Development Source Outlook (Revenue, USD Million, 2018 - 2030)
- Mammalian
- Microbial
- Others
- Biologics Contract Development Service Outlook (Revenue, USD Million, 2018 - 2030)
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Biologics Contract Development Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Immunological Disorders
- Cardiovascular Disorders
- Hematological Disorders
- Others
- Biologics Contract Development Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- North America Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- North America Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- The U.S.
- U.S. Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- U.S. Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- U.S. Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- U.S. Biologics Contract Development Market, by Source
- Canada
- Canada Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Canada Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Canada Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Canada Biologics Contract Development Market, by Source
- Europe
- Europe Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Europe Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Europe Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- UK
- UK Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- UK Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- UK Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- UK Biologics Contract Development Market, by Source
- Germany
- Germany Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Germany Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Germany Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Germany Biologics Contract Development Market, by Source
- France
- France Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- France Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- France Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- France Biologics Contract Development Market, by Source
- Italy
- Italy Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Italy Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Italy Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Italy Biologics Contract Development Market, by Source
- Spain
- Spain Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Spain Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Spain Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Spain Biologics Contract Development Market, by Source
- Denmark
- Denmark Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Denmark Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Denmark Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Denmark Biologics Contract Development Market, by Source
- Sweden
- Sweden Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Sweden Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Sweden Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Sweden Biologics Contract Development Market, by Source
- Norway
- Norway Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Norway Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Norway Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Norway Biologics Contract Development Market, by Source
- Europe Biologics Contract Development Market, by Source
- Asia Pacific
- Asia Pacific Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Asia Pacific Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Asia Pacific Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Japan
- Japan Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Japan Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Japan Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Japan Biologics Contract Development Market, by Source
- China
- China Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- China Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- China Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- China Biologics Contract Development Market, by Source
- India
- India Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- India Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- India Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- India Biologics Contract Development Market, by Source
- Australia
- Australia Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Australia Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Australia Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Australia Biologics Contract Development Market, by Source
- South Korea
- South Korea Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- South Korea Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- South Korea Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- South Korea Biologics Contract Development Market, by Source
- Thailand
- Thailand Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Thailand Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Thailand Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Thailand Biologics Contract Development Market, by Source
- Asia Pacific Biologics Contract Development Market, by Source
- Latin America
- Latin America Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Latin America Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Latin America Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Brazil
- Brazil Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Brazil Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Brazil Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Brazil Biologics Contract Development Market, by Source
- Mexico
- Mexico Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Mexico Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Mexico Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Mexico Biologics Contract Development Market, by Source
- Argentina
- Argentina Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Argentina Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Argentina Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Argentina Biologics Contract Development Market, by Source
- Colombia
- Colombia Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Colombia Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Colombia Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Colombia Biologics Contract Development Market, by Source
- Latin America Biologics Contract Development Market, by Source
- Middle East & Africa
- Middle East & Africa Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Middle East & Africa Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Middle East & Africa Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- South Africa
- South Africa Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- South Africa Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- South Africa Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- South Africa Biologics Contract Development Market, by Source
- Saudi Arabia
- Saudi Arabia Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Saudi Arabia Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Saudi Arabia Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Saudi Arabia Biologics Contract Development Market, by Source
- UAE
- UAE Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- UAE Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- UAE Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- UAE Biologics Contract Development Market, by Source
- Kuwait
- Kuwait Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Kuwait Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Kuwait Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Kuwait Biologics Contract Development Market, by Source
- Middle East & Africa Biologics Contract Development Market, by Source
- North America Biologics Contract Development Market, by Source
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
